A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.

H LapeereM BaeckA StockmanV SabatoM GrosberM MoutschenJ LambertL VandebuerieLaurence de MontjoyeH RabijnsK AllewaertR Schrijvers

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)

This study revealed that patients initiated on omalizumab in Belgium had severe CSU at baseline, and showed substantial improvements after 1 month of treatment. Greater adherence to the prescription of guideline-recommended medications is needed for the treatment of CSU.

Keyphrases

end stage renal disease
type diabetes
ejection fraction
patient reported outcomes
early onset
prognostic factors
combination therapy
single cell
weight loss
glycemic control
patient reported